Oaktree Acquisition Corp. III Life Sciences
public_traded
Oaktree Acquisition Corp. III Life Sciences is publicly traded on NASDAQ under ticker OACC.
Oaktree Acquisition Corp. III Life Sciences focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It intends to acquire companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.